Randomised controlled trial of mixed whole-cell/acellular pertussis vaccination versus acellular-only vaccination of infants

Richmond, Peter (Investigator 01)
Marsh, Julie (Investigator 02)

Status	Finished
Effective start/end date	1/01/20 → 31/12/24

Funding

NHMRC National Health and Medical Research Council : A$372,250.00

2 Article

Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial
Chacón, G. P., Estcourt, M. J., Totterdell, J., Marsh, J. A., Perrett, K. P., Campbell, D. E., Wood, N., Gold, M., Waddington, C. S., Sullivan, M. O., McAlister, S., Curtis, N., Jones, M., McIntyre, P. B., Holt, P. G., Richmond, P. C. & Snelling, T., 10 Jun 2024, (E-pub ahead of print) In: PLoS Medicine. 21, 6 , e1004414.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Citation (Scopus)
Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
Totterdell, J. A., Chacon, G. P., Estcourt, M. J., Jones, M., Richmond, P., Snelling, T. L. & Marsh, J. A., Dec 2022, In: Trials. 23, 1, 121.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)